255 publications
Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
Zorginstituut Nederland has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone (Raxone®) is not ...
Programme ‘Outcome Information for Shared Decision-Making’ - factsheet
Project: ‘ICHOM as an accelerator for outcome information’ - factsheet
Glycerol phenylbutyrate (Ravicti®) for the treatment of urea-cycle disorders
Zorginstituut Nederland has carried out an assessment of the medicinal product glycerol phenylbutyrate (Ravicti®) for the ...
Zinnige Zorg room for improvement report - In-depth phase neoplasms: care during the final stage of life of patients with incurable intestinal or lung cancer
The final stage of life is one in which a patient is of an advanced age or has a disease and/or is in a phase of a disease that ...
Cetuximab (Erbitux®) for the treatment of metastatic colorectal cancer
Zorginstituut Nederland has carried out a re-assessment of the medicinal product cetuximab (Erbitux®), whereby they came to the ...
Acarizax® in cases of allergic rhinitis due to house dust mite
Zorginstituut Nederland carried out an assessment of whether the medicinal product Acarizax® is interchangeable with a drug ...
A paradigm shift in perception, learning and action - core of the second advice of the Committee Innovation Health Care Professions & Education
Translation of the core of the second advice of The Committee Innovation Health Care Professions & Education.
Tenofovir alafenamide (Vemlidy®) for the treatment of chronic hepatitis B infection
Zorginstituut Nederland carried out an assessment of the medicine tenofovir alafenamide (Vemlidy®). Based on the criteria of the ...
Migalastat (Galafold®) for the treatment of Fabry's disease
Zorginstituut Nederland carried out an assessment of whether, based on the criteria of the Medicines Reimbursement System (GVS), ...